Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine and gemcitabine in pretreated metastatic breast cancer (Phase II)
2005-003403-36Phase 2Terminated
- Sponsor
- AOU Policlinico di Modena
- Start
- Apr 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of capecitabine and gemcitabine in breast cancer, sponsored by AOU Policlinico di Modena. Started Apr 2007; status: terminated.
02
Drugs
capecitabinegemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-003403-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003403-36.